What one share of Biorestorative Therapies holds
Biorestorative Therapies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $0.03 |
|---|---|
| Profit | −$0.98 |
| Cash and investments | $0.14 |
| Book value | $0.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.20 | −$28.56 | — | — | — | −$1.86 |
| 2021 | $0.04 | −$37.30 | $0.03 | −$2.83 | — | — |
| 2022 | $0.03 | −$3.65 | $0.07 | −$1.71 | — | $2.80 |
| 2023 | $0.03 | −$2.47 | $0.04 | −$1.56 | — | $2.12 |
| 2024 | $0.05 | −$1.16 | $0.01 | −$1.07 | — | $1.23 |
| 2025 | $0.04 | −$1.58 | $0.01 | −$1.21 | — | $0.04 |
Common questions about Biorestorative Therapies
How much does one share of Biorestorative Therapies earn?
Over the last 12 months, Biorestorative Therapies lost $0.98 for each share on $0.03 of sales.
Does Biorestorative Therapies pay a dividend?
Biorestorative Therapies didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biorestorative Therapies’s book value per share?
Biorestorative Therapies’s book value is $0.12 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of March 31, 2026.
How much cash and debt does each share of Biorestorative Therapies have?
Each share of Biorestorative Therapies has $0.14 of cash and investments, as of March 31, 2026.
Has Biorestorative Therapies bought back shares?
Biorestorative Therapies’s share count rose about 2178% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.